Showing 16,581 - 16,600 results of 27,028 for search '(( 100 ((nn decrease) OR (teer decrease)) ) OR ( 50 ((mean decrease) OR (a decrease)) ))', query time: 0.84s Refine Results
  1. 16581

    Intracellular chloride measurements by Wallace B Thoreson (5462)

    Published 2011
    “…An example of the reduction in MEQ fluorescence, indicating an increase in intracellular [Cl], produced by application of 12.1 mM Kto a cone. C. A greater decrease in MEQ fluorescence was produced by application of 69.9 mM K. …”
  2. 16582

    Oosthuizen et al. Data.pdf by Tasha Oosthuizen (19200784)

    Published 2024
    “…When the night light originated remotely from a corner of the room, activity levels decreased by more than 50%, whereas under direct ALAN from above the cages, there was a 75% decrease in activity. …”
  3. 16583

    Correlational learning rule for regulation of vestibular synapse strength by cerebellar inhibition: transfer of VOR gain from cerebellar cortex to brainstem. by John R. W. Menzies (361198)

    Published 2013
    “…During training the cerebellum has learnt to produce an inhibitory input modulated in phase with the vestibular input, leading to cancellation which produces a 50% gain decrease (since and , a weight requires ). …”
  4. 16584

    Functional Lung Imaging during HFV in Preterm Rabbits by Jordan Thurgood (123527)

    Published 2012
    “…Whilst ventilated at fixed pressures, each animal was ventilated at frequencies of 1, 3, 5 and 10 Hz. A 50% decrease in delivered tidal volume was measured at 10 Hz compared to 1 Hz, yet at the higher frequency a 500% increase in minute activity was measured. …”
  5. 16585

    Substrate binding specificity of purified OpuAC. by Justina C. Wolters (207763)

    Published 2010
    “…The inhibition experiments with proline and carnitine show a decrease in the ΔF<sub>max</sub> at increased concentrations of inhibitor, which is caused by the high concentrations of inhibitor (see panel A and B). …”
  6. 16586

    Data_Sheet_1_Drug-Tolerant Idling Melanoma Cells Exhibit Theory-Predicted Metabolic Low-Low Phenotype.docx by Dongya Jia (3897142)

    Published 2020
    “…L/L metabolism is unfavorable for tumor growth, yet supports successful cell division at ~50% rate. Thus, L/L drug-tolerant idling cells are a reservoir for accumulating mutations responsible for relapse, and it should be considered as a target subpopulation for improving MAPKi outcomes in melanoma treatment.…”
  7. 16587

    Supplemental_Figure_of_Imeglimin_ameliorate_SA-AKI by Hiroyasu Goto (12227927)

    Published 2025
    “…Data are presented as the mean ± SE. Data were analyzed using a two-way analysis of variance (ANOVA) with Šidák’s post-hoc test #p<0.05. …”
  8. 16588

    Effect of environmental factors on the germination of Megathyrsus maximus: an invasive weed in sugarcane in Argentina by Debora C. Cabrera (10460723)

    Published 2021
    “…Both mean germination percentages and CG decreased as osmotic potential became increasingly negative (0 MPa to -0.6 MPa), and as sodium chloride solution concentrations increased (10 to 130 mmol L-1). …”
  9. 16589

    The effects of purmorphamine and Msi1 knockdown on p21<sup>CIP1,WAF1</sup> and c-Myc expression. by In-Sun Hong (284033)

    Published 2013
    “…Purmorphamine treatment decreased and increased the expression of p21<sup>CIP1,WAF1</sup> (<b>A</b>) and c-Myc (<b>B</b>), respectively. …”
  10. 16590
  11. 16591
  12. 16592
  13. 16593
  14. 16594
  15. 16595
  16. 16596
  17. 16597

    Astilbin exerts anti-hypersensitivity by regulating metabolic demand and neuronal activity in rodent model of neuropathic pain by Qiru Wang (12260453)

    Published 2024
    “…</p> <p>In experiments conducted on neuropathic rats, both systemic and intrathecal administration of astilbin, an essential constituent, exhibited a noteworthy and dose-dependently decrease in chronic and acute pain behaviours. …”
  18. 16598
  19. 16599

    Tubulin-Destabilizing Agent BPR0L075 Induces Vascular-Disruption in Human Breast Cancer Mammary Fat Pad Xenografts by Li Liu (75607)

    Published 2012
    “…The current study evaluated the vascular-disrupting activity of BPR0L075 in human breast cancer mammary fat pad xenografts using dynamic bioluminescence imaging. A single dose of BPR0L075 (50 mg/kg, intraperitoneally (i.p.)) induced rapid, temporary tumor vascular shutdown (at 2, 4, and 6 hours); evidenced by rapid and reproducible decrease of light emission from luciferase-expressing orthotopic MCF7 and MDA-MB-231 breast tumors after administration of luciferin substrate. …”
  20. 16600